Requires health insurance policies to cover comprehensive genetic screening and FDA approved biomarker testing for ovarian and prostate cancers.
- Chamber
- House
- Introduced
- Mar 5, 2025
- Last action
- Jan 7, 2026 — REFERRED TO INSURANCE
- Session
- 2025-2026
- Momentum
- 27 · Low